Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience

Summary

The goal of this clinical trial is to test the effect of digitally delivered programs on the health, wellbeing, and functioning of newly diagnosed cancer patients. Participants will be randomized to one of two digital programs. Both groups are equally important for the study. Participants will be asked to complete: * Questionnaires. Answers to the questionnaires will help the investigators understand how participants doing through the study. * Modules. Participants will receive access to digital courses developed by experts at Stanford University. * Blood Samples. At home blood collection kits will help the investigators understand how participants' bodies are responding over time. Kits will be sent and returned by mail.

Eligibility

Inclusion Criteria:

* Initial (non-recurrent) diagnosis of non-metastatic (stage I-III) or hematological malignancy.
* Diagnosis in the past 150 days.
* Currently receiving active systemic treatment or with a planned systemic treatment (including chemotherapy, immunotherapy or other targeted therapies).
* Eighteen years of age or older.
* Fluent in English.
* Currently reside in the United States.
* Access to a computer, tablet, or smartphone (a mobile phone that performs many of the functions of a computer, typically including a touchscreen interface, internet access, and an operating system capable of running downloaded applications, or tablet that runs iOS or Android software, with cellular data service or wifi access).

Exclusion Criteria:

* Failure to meet inclusion criteria.
* Currently receiving treatment for severe depression, severe anxiety, bipolar disorder, post-traumatic stress disorder, or schizophrenia.

Conditions1

Locations1 site

Browse More Trials